A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.
Carvedilol has been studied across 18 research domains including ❤️ Cardiovascular, 🫁 Liver & Detox, 🔬 Inflammation, 🦴 Bone & Joint, 🔥 Metabolic. The primary research focus is ❤️ Cardiovascular with 55% of studies addressing this area.
The following compounds share molecular targets with Carvedilol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Carvedilol is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.